A Comprehensive Review of the Advancement in Omic Technologies in the
Field of Drug Discovery and Development

Mridula      Chauhan; Shivansh      Kumar; Arpon      Biswas; Mukesh      Kumar; Sarvesh   Kumar   Verma; Anjali      Mishra; Vaishali      Singh; Amol   Chhatrapati   Bisen; Sristi      Agrawal; Abhijit   Deb   Choudhury; Ramkrishna      Rayiti; Rabi   Sankar   Bhatta

doi:10.2174/0115701808287654240126112003

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

Abstract

Discovering new drugs is time-consuming and expensive and involves many different tools from various domains. Numerous omic technologies, such as genomics, transcriptomics, proteomics, and metabolomics, have been created to speed up the process. Leveraging genetic and genomic insights, these methodologies play a pivotal role. Genetic insights aid in target identification, prioritization, and the prediction of drug outcomes. Gene expression data informs drug discovery, while proteomics uncovers targets and facilitates high-throughput profiling. Enhancing drug efficacy necessitates mechanistic insights into downstream effects, enabling side effects and resistance prediction. Early-stage drug discovery now extensively employs diverse metabolomics platforms. This review underscores the recent strides of omic technologies in drug discovery, affirming their role in enhancing drug viability and regulatory approval. The emphasis lies on the latest advancements in genomics, transcriptomics, proteomics, and metabolomics, collectively fortifying drug development.

Keywords: Omic technology, genomics, transcriptomics, proteomics, metabolomics

Rights & Permissions Print Cite

Article Metrics

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0115701808287654240126112003	Print ISSN 1570-1808
Publisher Name Bentham Science Publisher	Online ISSN 1875-628X

Letters in Drug Design & Discovery

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development

Abstract

Related Journals

Related Books